Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
G protein-coupled receptors
Biotech
Lilly-backed Superluminal speeds toward the clinic with $120M
The Boston-based biotech focuses on G protein-coupled receptors, which are proteins embedded in the membranes of cells.
Darren Incorvaia
Sep 9, 2024 7:00am
AbbVie buys antibody-focused biotech DJS for $255M
Oct 20, 2022 12:40pm
Former Janssen US oncology chief to lead Teon Therapeutics
Mar 8, 2022 5:30am
Septerna launches with $100M and GPCR pioneer co-founder
Jan 27, 2022 7:00am
Regeneron pinpoints gene variants that protect against obesity
Jul 1, 2021 2:00pm